Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

As with any prescription medication, there are side effects of Wegovy to keep in mind. The most common side effects are ...

For some, the issue with GLP-1 drugs like Ozempic and Mounjaro isn't getting access to these game-changing medications, but ...

Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...

2020年以来，诺和诺德的股价不断创出新高，期间最高涨幅超过450%，折合年化收益超越30%。立足于糖尿病治疗领域，这家百年制药企业凭借其在肥胖症治疗领域的突破性成果，吸引着全球投资者的目光。今年前三季度，诺和诺德的整体销售额同比增长23%，肥胖症治 ...

Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% ...

11月18日，丹麦大型制药企业诺和诺德（NovoNordisk）发布消息称，已开始在中国销售减肥药物“Wegovy”。受肥胖困扰的人呈现增加趋势的中国一直被视为减肥药物的潜力市场。与减肥药率先普及的美国市场相比，诺和诺德预计将以较低的价格来开拓当地需 ...

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each ...

Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...